AstraZeneca Aktie
120,65
EUR
+1,55
EUR
+1,30
%
100,24
GBP
+1,09
GBP
+1,10
%
AstraZeneca Aktie Analyse
03.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
28.05.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
24.05.19 | AstraZeneca overweight | Barclays Capital | |
13.05.19 | AstraZeneca buy | Kepler Cheuvreux | |
10.05.19 | AstraZeneca buy | Deutsche Bank AG | |
30.04.19 | AstraZeneca buy | Deutsche Bank AG | |
26.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
24.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
10.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
05.04.19 | AstraZeneca buy | Deutsche Bank AG | |
03.04.19 | AstraZeneca buy | Kepler Cheuvreux | |
01.04.19 | AstraZeneca overweight | Barclays Capital | |
01.04.19 | AstraZeneca buy | Deutsche Bank AG | |
29.03.19 | AstraZeneca Outperform | Credit Suisse Group | |
29.03.19 | AstraZeneca overweight | Barclays Capital | |
29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
05.03.19 | AstraZeneca buy | Deutsche Bank AG | |
26.02.19 | AstraZeneca buy | Deutsche Bank AG | |
26.02.19 | AstraZeneca overweight | Barclays Capital | |
25.02.19 | AstraZeneca overweight | Barclays Capital | |
18.02.19 | AstraZeneca buy | Deutsche Bank AG | |
15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
14.01.19 | AstraZeneca buy | Deutsche Bank AG | |
02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
14.12.18 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
07.12.18 | AstraZeneca Outperform | Credit Suisse Group | |
19.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
16.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
13.11.18 | AstraZeneca buy | Deutsche Bank AG | |
12.11.18 | AstraZeneca buy | Deutsche Bank AG | |
09.11.18 | AstraZeneca Outperform | Credit Suisse Group | |
09.11.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
09.11.18 | AstraZeneca overweight | Barclays Capital | |
30.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
22.10.18 | AstraZeneca buy | Deutsche Bank AG | |
19.10.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
08.10.18 | AstraZeneca buy | Deutsche Bank AG | |
26.09.18 | AstraZeneca buy | Deutsche Bank AG | |
25.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
18.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
11.09.18 | AstraZeneca Outperform | BNP PARIBAS | |
07.09.18 | AstraZeneca buy | Kepler Cheuvreux | |
30.08.18 | AstraZeneca Outperform | Credit Suisse Group | |
10.08.18 | AstraZeneca overweight | Barclays Capital | |
07.08.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
01.08.18 | AstraZeneca buy | Kepler Cheuvreux |